Artesunate for the treatment of severe falciparum malaria.
Rosenthal
Philip J
PJ
Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94143, USA. prosenthal@medsfgh.ucsf.edu
D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D037621:Artemisinins / Q000009:adverse effects / Q000627:therapeutic use*; D000077332:Artesunate; D006801:Humans; D008018:Life Cycle Stages; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000254:growth & development*; D017410:Practice Guidelines as Topic; D012717:Sesquiterpenes / Q000009:adverse effects / Q000627:therapeutic use*
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; D000077332:Artesunate